subject: UMLS:C3898587

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma

tested_intervention: unsure


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:167656

subject_name: Brivanib alaninate

object_name: Advanced cancer


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:63605

subject_name: Ixabepilone


subject: CHEBI:45863

subject_name: Paclitaxel

tested_intervention: yes


subject: UNII:958Y70F3HQ

object_name: endogenous depression


subject: UNII:958Y70F3HQ

object_name: major depressive disorder


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: ovarian cancer


subject: UMLS:C4053604

subject_name: Phosphaplatin PT-112

object_name: non-small cell lung carcinoma


subject: CHEBI:91464

object_name: mast cell leukemia


subject: CHEBI:63452

subject_name: Midostaurin


subject: UNII:LIA7Z4002P

subject_name: Nadroparin

object_name: Mechanical ventilation finding


subject: UNII:LIA7Z4002P


subject: UNII:LIA7Z4002P

object_name: Anticoagulants and Bleeding Disorders


subject: UMLS:C5557579

subject_name: AsiDNA


subject: UMLS:C5557579

object_name: ovarian neoplasm


subject: UMLS:C5557579

object_name: ovarian carcinoma


subject: CHEBI:134689

subject_name: Rucaparib


subject: CHEBI:134689


subject: CHEBI:134689


subject: UNII:Z1HHM49K7O

subject_name: Napabucasin

object_name: metastatic colorectal cancer


subject: CHEBI:27470

subject_name: Folic acid

object_name: colorectal neoplasm


subject: UNII:48IAF3FDP3

subject_name: ISIS 5132


subject: UNII:48IAF3FDP3


subject: UNII:48IAF3FDP3


subject: UMLS:C0051978

subject_name: Anti-Immunoglobulin E antibody

object_name: Allergy


subject: UMLS:C0051978

object_name: History of allergies


subject: UMLS:C2825096

subject_name: Anti-IgE [EPC]


subject: UMLS:C2825096


subject: UMLS:C3537103

subject_name: Nucleoside Reverse Transcriptase Inhibitor

object_name: HIV infection


subject: UMLS:C0595042

subject_name: Twinrix Adult

object_name: hepatitis A


subject: UMLS:C0595042

object_name: hepatitis B


subject: UMLS:C1170689

subject_name: Twinrix Junior


subject: UMLS:C1170689


subject: PUBCHEM.COMPOUND:78384800

subject_name: Taxanes

object_name: breast neoplasm


subject: UMLS:C0796419


subject: UMLS:C3541958

subject_name: Taxanes, antineoplastic


subject: UMLS:C5239568

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Neonatal hypotension


subject: CHEBI:17650

object_name: Neonatal Hypotension, AE


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: bacterial conjunctivitis


subject: CHEBI:261649

subject_name: Bismuth subsalicylate

object_name: Helicobacter pylori infection


subject: CHEBI:85545

subject_name: Bismuth cation


subject: CHEBI:33301

subject_name: bismuth atom


subject: UMLS:C2917658

subject_name: Bismuth [EPC]


subject: PUBCHEM.COMPOUND:54675776

subject_name: tetracycline


subject: PUBCHEM.COMPOUND:54685734

subject_name: Epitetracycline


subject: UMLS:C1744619

subject_name: Tetracycline Antibiotics


subject: CHEBI:188074

object_name: schizophrenia


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: DRUGBANK:DB16582

subject_name: Lisocabtagene maraleucel

object_name: indolent B-cell non-Hodgkin lymphoma


subject: DRUGBANK:DB16582

object_name: Non-Hodgkin's lymphoma refractory


subject: DRUGBANK:DB16582

object_name: high grade B-cell lymphoma


subject: DRUGBANK:DB16582

object_name: primary mediastinal large B-cell lymphoma


subject: DRUGBANK:DB16582

object_name: follicular lymphoma


subject: DRUGBANK:DB16582

object_name: diffuse large B-cell lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108570

subject_name: ABOBOTULINUMTOXINA

object_name: Glabellar frown lines


subject: UMLS:C2729275

subject_name: INJECTION, ABOBOTULINUMTOXINA, 5 UNITS


subject: UNII:75HI05N8HS

object_name: acute myeloid leukemia


subject: UMLS:C5237451

subject_name: Menin-MLL Inhibitor SNDX-5613


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: Deep endometriosis


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UMLS:C4053599

object_name: Geographic atrophy


subject: UMLS:C0034862

subject_name: Vaccines, Recombinant

object_name: androgen insensitivity syndrome


subject: UMLS:C0034862

object_name: androgen insensitivity syndrome, non-human animal


subject: UMLS:C0034862

object_name: scoliosis, isolated, susceptibility to, 1


subject: UMLS:C0034862

object_name: adenocarcinoma in situ


subject: UMLS:C0034862

object_name: Cervical intraepithelial neoplasia grade 2


subject: UMLS:C0034862

object_name: Cervical intraepithelial neoplasia grade 1


subject: UMLS:C0034862

object_name: uterine cervix carcinoma in situ


subject: UMLS:C0034862

object_name: cervical cancer


subject: UMLS:C0034862

object_name: cervical carcinoma


subject: UMLS:C0034862

object_name: Genital warts


subject: UMLS:C0034862

object_name: vaginal cancer


subject: UMLS:C0034862

object_name: vaginal carcinoma


subject: UMLS:C0034862

object_name: vulva cancer


subject: UMLS:C0034862

object_name: vulva carcinoma


subject: UMLS:C0034862

object_name: Vulval intraepithelial neoplasia grade 2


subject: UMLS:C0034862

object_name: low grade vulvar intraepithelial neoplasia


subject: CHEBI:74947

subject_name: Thalidomide

object_name: adult lymphoma


subject: CHEBI:74947

object_name: lymphoma


subject: CHEBI:74947

object_name: pediatric lymphoma


subject: CHEBI:95341

subject_name: Baricitinib

object_name: Depressed mood


subject: CHEBI:95341

object_name: Cancer patients and suicide and depression


subject: CHEBI:95341

object_name: Depressed - symptom


subject: CHEBI:95341

object_name: Depression, CTCAE


subject: CHEBI:95341

object_name: Anhedonia


subject: CHEBI:95341

object_name: HIV infection


subject: CHEBI:6931

subject_name: Midazolam

object_name: Midazolam overdose


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: acute necrotizing pancreatitis


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: CHEBI:43968

subject_name: Meropenem


subject: UNII:2AD53WQ2CX

object_name: Drug Interactions


subject: UNII:2AD53WQ2CX

object_name: Adverse drug interaction


subject: CHEBI:63660


subject: CHEBI:63660


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:63618


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: severe acute respiratory syndrome (SARS) pneumonia


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: retinopathy of prematurity


subject: CHEBI:81579

object_name: exudative vitreoretinopathy 1


subject: CHEBI:81579

object_name: Retinopathy of Prematurity, AE


subject: CHEBI:32660

subject_name: asparaginase

object_name: Childhood Acute Lymphoblastic Leukemia in Remission


subject: CHEBI:32660

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:94265


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41977


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:4911

subject_name: Etoposide


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:45783

subject_name: Imatinib


subject: CHEBI:45783


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:5062

subject_name: Finasteride

object_name: retinal disease


subject: UMLS:C3827148

subject_name: BP-Cx1-Platinum Complex BP-C1

object_name: Carcinoma breast stage IV


subject: UMLS:C3827148

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C3827148

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C3827148

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:6916

subject_name: Mexiletine

object_name: myotonic dystrophy type 1


subject: CHEBI:6916

object_name: myotonic dystrophy


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: mild neurocognitive disorder


subject: PUBCHEM.COMPOUND:521372

object_name: mild cognitive impairment


subject: CHEBI:33704

subject_name: Amino acid

object_name: type 2 diabetes mellitus


subject: CHEBI:33704

object_name: Diabetes


subject: CHEBI:33704

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:169449957

subject_name: Amino Acids


subject: PUBCHEM.COMPOUND:169449957


subject: PUBCHEM.COMPOUND:169449957


subject: CHEMBL.COMPOUND:CHEMBL1201498

subject_name: AMINO ACIDS


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: UMLS:C3539946

subject_name: Amino Acids, I.V. solution additive


subject: UMLS:C3539946


subject: UMLS:C3539946


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C3539947

subject_name: Antifibrinolytic amino acids


subject: UMLS:C3539947


subject: UMLS:C3539947


subject: UMLS:C1456762

object_name: keratosis


subject: UMLS:C1456762

object_name: Keratoma


subject: CHEBI:83766

subject_name: Olaparib

object_name: non-small cell lung carcinoma


subject: CHEBI:44915

subject_name: Propofol

object_name: Myocardial injury


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: rickets


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UNII:MH5DMF9JKY

subject_name: Emavusertib

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:118224238


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib


subject: PUBCHEM.COMPOUND:169490832

object_name: cancer


subject: PUBCHEM.COMPOUND:169490832

object_name: neoplasm


subject: CHEBI:94809

subject_name: Itopride

object_name: gastroparesis


subject: CHEBI:94809

object_name: Gastroparesis, CTCAE


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: bipolar disorder


subject: CHEBI:7421

subject_name: NAC


subject: UMLS:C5543952

object_name: Alzheimer disease


subject: UNII:LT369U66CE

subject_name: Ibalizumab

object_name: HIV-1 infection


subject: CHEBI:71196

subject_name: glucagon-like peptide-1 receptor agonist

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:71196

object_name: obesity


subject: CHEBI:71196

object_name: Obesity, CTCAE


subject: CHEBI:71196

object_name: Mental health issue


subject: CHEBI:71196

object_name: diabetes mellitus


subject: UMLS:C2917359

subject_name: GLP-1 Receptor Agonist [EPC]


subject: UMLS:C2917359


subject: UMLS:C2917359


subject: UMLS:C2917359


subject: UMLS:C2917359


subject: CHEMBL.COMPOUND:CHEMBL3545031

object_name: asthma


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:49662

subject_name: Indomethacin

object_name: patent ductus arteriosus


subject: CHEBI:39867

subject_name: Valproic acid

object_name: Seizure Related to COVID-19


subject: CHEBI:39867

object_name: visual epilepsy


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: Childhood Breast Carcinoma


subject: CHEBI:168243

object_name: breast carcinoma


subject: CHEBI:168243

object_name: breast cancer


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: PUBCHEM.COMPOUND:20734893

subject_name: Fluticasone furoate

object_name: rhinitis


subject: CHEBI:5134

subject_name: Fluticasone


subject: UMLS:C2000258

object_name: mantle cell lymphoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Metastatic carcinoma to liver


subject: UNII:DPT0O3T46P

object_name: colorectal adenocarcinoma


subject: CHEBI:6801

subject_name: Metformin

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:6801

object_name: Non-small cell lung cancer stage III


subject: CHEBI:6801

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:6801

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:6801

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:9T210MMZ3F

subject_name: Blarcamesine

object_name: Rett syndrome


subject: UMLS:C5700351


subject: UNII:RZ22DI43TP

subject_name: PROTHROMBIN COMPLEX CONCENTRATE

object_name: Intracranial hemorrhage


subject: UMLS:C0072434

subject_name: prothrombin complex concentrates


subject: UMLS:C4048712

subject_name: factor IX complex


subject: PUBCHEM.COMPOUND:54675776

subject_name: tetracycline

object_name: Burn injury


subject: PUBCHEM.COMPOUND:54675776

object_name: Burn, CTCAE


subject: PUBCHEM.COMPOUND:54685734

subject_name: Epitetracycline


subject: PUBCHEM.COMPOUND:54685734


subject: UMLS:C1744619

subject_name: Tetracycline Antibiotics


subject: UMLS:C1744619


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UNII:3A189DH42V

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:169D1260KM

subject_name: NITROPRUSSIDE

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:129696905


subject: UMLS:C0590690

subject_name: Imdur


subject: CHEBI:6062

subject_name: Isosorbide mononitrate


subject: CHEBI:185031


subject: CHEBI:28498

subject_name: Acadesine


subject: CHEBI:2030

subject_name: orazamide


subject: CHEBI:18406

subject_name: AICAR


subject: CHEBI:77733

subject_name: Verapamil


subject: PUBCHEM.COMPOUND:25101755

object_name: monkeypox


subject: UNII:F925RR824R

subject_name: Tecovirimat


subject: GTOPDB:12652

subject_name: magrolimab

object_name: Myelodysplasia


subject: GTOPDB:12652

object_name: acute myeloid leukemia by FAB classification


subject: GTOPDB:12652

object_name: acute myeloid leukemia


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: hypertension


subject: CHEBI:26710

object_name: Hypertension, CTCAE


subject: CHEBI:15365

subject_name: Aspirin

object_name: Atherothrombosis


subject: CHEBI:94721

subject_name: Triflusal


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: rheumatoid arthritis


subject: CHEBI:232920

object_name: voice disorders


subject: CHEBI:232920

object_name: Dysphonia


subject: CHEBI:232920

object_name: Hoarse voice


subject: PUBCHEM.COMPOUND:65020

subject_name: APA


subject: PUBCHEM.COMPOUND:65020


subject: PUBCHEM.COMPOUND:65020


subject: CHEBI:53713

subject_name: ampicillanyl group


subject: CHEBI:53713


subject: CHEBI:53713


subject: UniProtKB:P46842

subject_name: APA_MYCLE Alanine and proline-rich secreted protein Apa (sprot)


subject: UniProtKB:P46842


subject: UniProtKB:P46842


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Adhesive Capsulitis


subject: CHEBI:150712

object_name: frozen shoulder


subject: CHEBI:150712

object_name: bursitis


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Childhood Breast Carcinoma


subject: CHEBI:7986

object_name: breast carcinoma


subject: CHEBI:7986

object_name: breast cancer


subject: PR:000001543

subject_name: programmed cell death 1 ligand 1

object_name: Stage I Bladder Cancer AJCC v8


subject: PR:000001543

object_name: Stage 0a Bladder Cancer AJCC v8


subject: PR:000001543

object_name: Stage 0is Bladder Cancer AJCC v8


subject: PR:000001543

object_name: High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma


subject: UMLS:C2986400

subject_name: Indoleamine 2,3-dioxygenase Peptide Vaccine


subject: UMLS:C2986400


subject: UMLS:C2986400


subject: UMLS:C2986400


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: chronic kidney disease


subject: UMLS:C0013227

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: CHEBI:63635

subject_name: Valganciclovir

object_name: localized Castleman disease


subject: CHEBI:63635

object_name: Castleman disease


subject: PUBCHEM.COMPOUND:70105374

subject_name: Pitavastatin Lactone

object_name: cardiovascular disorder


subject: CHEBI:32020

subject_name: Pitavastatin


subject: UMLS:C5783829

subject_name: Anti-SIRPa Monoclonal Antibody BI 770371

object_name: head and neck squamous cell carcinoma


subject: UMLS:C3272757

subject_name: Live attenuated Influenza virus antigen only vaccine product

object_name: respiratory tract infectious disorder


subject: UMLS:C3272757

object_name: habits (history)


subject: CHEBI:188074

object_name: Androgen excess


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: severe acute respiratory syndrome


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: DS Stage I Plasma Cell Myeloma


subject: UNII:PVI5M0M1GW

object_name: ISS Stage I Plasma Cell Myeloma


subject: UNII:PVI5M0M1GW

object_name: ISS Stage II Plasma Cell Myeloma


subject: UNII:PVI5M0M1GW

object_name: ISS Stage III Plasma Cell Myeloma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:125354

subject_name: Plerixafor


subject: CHEBI:125354


subject: CHEBI:125354

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:125354


subject: CHEBI:125354


subject: CHEBI:125354

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:125354

object_name: Plasma cell myeloma refractory


subject: CHEBI:10119

subject_name: Ziprasidone

object_name: endogenous depression


subject: CHEBI:10119

object_name: major depressive disorder


subject: CHEBI:174615

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:174615

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:174615

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:174615


subject: CHEBI:174615

object_name: T-cell prolymphocytic leukemia


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:61080

subject_name: Romidepsin


subject: CHEBI:61080


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: CHEBI:167308

subject_name: Dextromethadone


subject: CHEBI:167308


subject: CHEBI:167308

object_name: Depressed mood


subject: CHEBI:167308

object_name: Cancer patients and suicide and depression


subject: CHEBI:167308

object_name: Depressed - symptom


subject: CHEBI:167308

object_name: Depression, CTCAE


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: Weight Fluctuation


subject: PUBCHEM.COMPOUND:3080587

object_name: Weight Change


subject: PUBCHEM.COMPOUND:3080587

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: primary ovarian failure


subject: UNII:4F4X42SYQ6

object_name: premature menopause


subject: UNII:4F4X42SYQ6

object_name: Autoimmunity


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C5417997

subject_name: BTK Inhibitor SAR442168

object_name: Multiple sclerosis relapse


subject: CHEBI:5847

subject_name: Raltitrexed

object_name: colorectal cancer


subject: CHEBI:5847

object_name: colorectal carcinoma


subject: CHEBI:5847

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: epicondylitis


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: UMLS:C4508898

object_name: schizophrenia


subject: CHEBI:166520

subject_name: Tenamfetamine

object_name: central diabetes insipidus


subject: CHEBI:166520

object_name: neurohypophyseal diabetes insipidus


subject: CHEBI:1391

subject_name: Midomafetamine


subject: CHEBI:1391


subject: MESH:C000706151

object_name: opiate dependence


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Primary dysmenorrhea


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: focal dystonia


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C5237036

subject_name: Docetaxel Polymeric Micelles

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5237036

object_name: Embolism, Tumor


subject: UMLS:C5237036

object_name: Neoplasm Metastasis


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: ichthyosis


subject: UNII:DLG4EML025

object_name: inherited ichthyosis


subject: UNII:DLG4EML025

object_name: lamellar ichthyosis


subject: UNII:DLG4EML025

object_name: Harlequin Fetus


subject: UNII:DLG4EML025

object_name: autosomal recessive congenital ichthyosis


subject: UNII:DLG4EML025

object_name: epidermolytic ichthyosis


subject: UNII:DLG4EML025

object_name: autosomal dominant epidermolytic ichthyosis


subject: UNII:DLG4EML025

object_name: Congenital ichthyosiform erythroderma


subject: UNII:DLG4EML025

object_name: Netherton syndrome


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Allodynia


subject: CHEBI:3160

object_name: Neuropathic pain


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: NK/T-cell lymphoma, nasal and nasal-type


subject: UMLS:C0876134

subject_name: Prevnar

object_name: mumps


subject: UMLS:C0876134

object_name: measles


subject: UMLS:C0876134

object_name: chickenpox


subject: UMLS:C0876134

object_name: rubella


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: rabies


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: MESH:D011819

subject_name: Rabies Vaccines


subject: CHEMBL.COMPOUND:CHEMBL2107909

subject_name: RABIES VACCINE


subject: UNII:I5I8VB78VT

subject_name: Erenumab

object_name: migraine


subject: UNII:I5I8VB78VT

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:50634

object_name: ADHF


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEMBL.COMPOUND:CHEMBL4594569

subject_name: AMLITELIMAB

object_name: atopic eczema


subject: UMLS:C5555444

subject_name: Amlitelimab


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus

object_name: pancreatic ductal adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Malignant pleural effusion


subject: MESH:D008081

subject_name: Liposomes


subject: CHEBI:60775

subject_name: Verteporfin


subject: CHEMBL.COMPOUND:CHEMBL5314346

subject_name: VERTEPORFIN


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: cystic fibrosis


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:31355

subject_name: Carboplatin


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox


subject: CHEBI:91899

object_name: perennial allergic rhinitis


subject: CHEBI:3207

subject_name: Budesonide


subject: PUBCHEM.COMPOUND:56841942

subject_name: Narlaprevir

object_name: Chronic hepatitis C genotype 1


subject: UMLS:C2974454

subject_name: narlaprevir


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: UMLS:C5434105

subject_name: Injection, sacituzumab govitecan-hziy, 2.5 mg

object_name: Lack of Expression of PD-L1


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UMLS:C3640943


subject: CHEMBL.COMPOUND:CHEMBL2108661

subject_name: VEHICLE

object_name: ocular hypertension


subject: CHEMBL.COMPOUND:CHEMBL2108661

object_name: Ocular hypertension


subject: CHEMBL.COMPOUND:CHEMBL2108661

object_name: glaucoma


subject: CHEMBL.COMPOUND:CHEMBL2108661

object_name: Glaucoma, CTCAE


subject: PUBCHEM.COMPOUND:11607546

subject_name: Sevikar

object_name: hypertension


subject: PUBCHEM.COMPOUND:11607546

object_name: Hypertension, CTCAE


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:45863

subject_name: Paclitaxel


subject: MESH:C000620181


subject: UMLS:C3273454


subject: UMLS:C0540301

subject_name: C1 esterase inhibitor

object_name: Inflammation


subject: UMLS:C0540301

object_name: Endotoxemia


subject: UMLS:C0009500

subject_name: Complement C1 Inactivator Proteins


subject: UMLS:C0009500


subject: UNII:39W1PKE3JI

subject_name: Bergamot oil

object_name: anxiety


subject: UNII:39W1PKE3JI

object_name: anxiety disorder


subject: UNII:39W1PKE3JI

object_name: Anxiety symptoms


subject: UNII:39W1PKE3JI

object_name: Anxiety, CTCAE 3.0


subject: UNII:39W1PKE3JI

object_name: Anxiety, CTCAE 5.0


subject: CHEMBL.COMPOUND:CHEMBL2108210

subject_name: LAVENDER OIL


subject: CHEMBL.COMPOUND:CHEMBL2108210


subject: CHEMBL.COMPOUND:CHEMBL2108210


subject: CHEMBL.COMPOUND:CHEMBL2108210


subject: CHEMBL.COMPOUND:CHEMBL2108210


subject: CHEBI:23359

subject_name: colchicine

object_name: peripheral vascular disease


subject: CHEBI:23359

object_name: peripheral arterial disease


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib

object_name: rheumatoid arthritis


subject: DRUGBANK:DB16341

subject_name: Tilsotolimod

object_name: Childhood Solid Neoplasm


subject: DRUGBANK:DB16341

object_name: Adult Solid Neoplasm


subject: DRUGBANK:DB16341

object_name: Solid Neoplasm


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Ectopic ossification


subject: CHEBI:31824

subject_name: Mesna

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:31824

object_name: non-Hodgkin lymphoma


subject: CHEBI:31824

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:31824

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: PUBCHEM.COMPOUND:137706467

subject_name: Rimiducid


subject: PUBCHEM.COMPOUND:137706467


subject: PUBCHEM.COMPOUND:137706467

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C4049035

subject_name: bupivacaine hydrochloride 7.5 MG/ML Injection

object_name: Post-Operative Pain


subject: CHEBI:194425

subject_name: Lobaplatin

object_name: Stomach cancer


subject: CHEBI:194425

object_name: gastric cancer


subject: CHEBI:194425

object_name: Surgical procedure finding


subject: CHEBI:194425

object_name: Effects of chemotherapy


subject: CHEBI:194425

object_name: Embolism, Tumor


subject: CHEBI:194425

object_name: Neoplasm Metastasis


subject: CHEBI:194425

object_name: Metastasis


subject: CHEBI:194425

object_name: Metastatic Lesion


subject: CHEBI:194425

object_name: survival time


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEBI:192744

subject_name: lobaplatin


subject: CHEBI:192744


subject: CHEBI:192744


subject: CHEBI:192744


subject: CHEBI:192744


subject: CHEBI:192744


subject: CHEBI:192744


subject: CHEBI:192744


subject: CHEBI:192744


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: CD274 Gene Mutation


subject: UMLS:C3641122


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: uveitis


subject: PUBCHEM.COMPOUND:633097

object_name: Uveitis, CTCAE


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: CHEBI:232540

object_name: Neck Carcinoma


subject: CHEBI:232540

object_name: head and neck neoplasm


subject: CHEBI:232540

object_name: head and neck cancer


subject: UMLS:C4086591

subject_name: MnSOD Mimetic BMX-001


subject: UMLS:C4086591


subject: UMLS:C4086591


subject: CHEMBL.COMPOUND:CHEMBL4297271


subject: CHEMBL.COMPOUND:CHEMBL4297271


subject: CHEMBL.COMPOUND:CHEMBL4297271


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:135918

object_name: primary cutaneous T-cell lymphoma


subject: GTOPDB:12990

subject_name: sintilimab


subject: GTOPDB:12990


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4510275

subject_name: Sulfur hexafluoride lipid microsphere

object_name: chronic kidney disease


subject: CHEBI:94714

subject_name: Doxofylline

object_name: chronic obstructive pulmonary disease


subject: MESH:C530970

subject_name: epaxal berna

object_name: inflammatory bowel disease


subject: MESH:C530970

object_name: hepatitis A


subject: MESH:C530970

object_name: Crohn disease


subject: MESH:C530970

object_name: ulcerative colitis


subject: MESH:C530970

object_name: inflammatory bowel disease 1


subject: MESH:C000592539

object_name: Advanced Malignant Solid Neoplasm


subject: MESH:C000592539

object_name: Plasma cell myeloma refractory


subject: MESH:C000592539

object_name: liver carcinoma


subject: UNII:TWQ8K8A81Y

subject_name: Larotaxel

object_name: bladder tumor


subject: UMLS:C2603884


subject: UMLS:C2742830

subject_name: Ismigen

object_name: Allergic rhinitis caused by grass pollen


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: multiple sclerosis


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Tinnitus, Subjective


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: giardiasis


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: aphthous stomatitis


subject: UNII:2WZP8A9VFN

subject_name: Vebreltinib

object_name: Activating MET Gene Mutation


subject: UNII:2WZP8A9VFN

object_name: MET Exon 14 Mutation


subject: UNII:2WZP8A9VFN

object_name: non-small cell lung carcinoma


subject: UNII:PH8858757I

object_name: type 2 diabetes mellitus


subject: UNII:PH8858757I

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:138713709

subject_name: deucravacitinib

object_name: Acne inversa


subject: PR:000003914

subject_name: AKT-interacting protein

object_name: Myelodysplasia


subject: PR:000003914

object_name: Adult Myelodysplastic Syndrome


subject: PR:000003914

object_name: childhood myelodysplastic syndrome


subject: PR:000003914

object_name: Myelodysplastic Syndrome, CTCAE


subject: PR:000003914

object_name: leukemia


subject: PR:000003914

object_name: childhood leukemia


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: metastatic neoplasm


subject: CHEBI:68646

object_name: Embolism, Tumor


subject: CHEBI:68646

object_name: Neoplasm Metastasis


subject: CHEBI:68646

object_name: Metastatic Lesion


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: PUBCHEM.COMPOUND:24743936

object_name: Partial Seizure


subject: CHEBI:49203

subject_name: Torcetrapib

object_name: hypercholesterolemia, familial, 1


subject: CHEBI:49203

object_name: familial hypercholesterolemia


subject: CHEBI:39548

subject_name: Atorvastatin


subject: CHEBI:39548


subject: UMLS:C5690526


subject: CHEBI:3757

subject_name: Clonidine

object_name: Agitation


subject: CHEBI:74705


subject: PR:000009425


subject: PR:000016318


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: HER2 gene amplification


subject: CHEBI:31348

subject_name: Capecitabine


subject: GTOPDB:8931


subject: CHEMBL.COMPOUND:CHEMBL4297556


subject: UMLS:C2827711


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:49603

subject_name: Lapatinib


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:4466

object_name: obesity


subject: CHEBI:4466

object_name: Obesity, CTCAE


subject: CHEBI:4466

object_name: Pathologic vasoconstriction


subject: CHEBI:4466

object_name: Vasoconstriction


subject: CHEBI:4466

object_name: Vasodilation disorder


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:33569

subject_name: noradrenaline


subject: CHEBI:33569


subject: CHEBI:33569


subject: CHEBI:33569


subject: CHEBI:33569


subject: CHEBI:33569


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:8081

subject_name: Phentolamine


subject: CHEBI:8081


subject: CHEBI:8081


subject: CHEBI:8081


subject: CHEBI:8081


subject: CHEBI:8081


subject: CHEBI:8093

subject_name: Phenylephrine


subject: CHEBI:8093


subject: CHEBI:8093


subject: CHEBI:8093


subject: CHEBI:8093


subject: CHEBI:8093


subject: GTOPDB:4977

object_name: HIV infection


subject: UMLS:C0123759


subject: UMLS:C1328728


subject: PR:000002995

subject_name: natural resistance-associated macrophage protein 2 isoform 1

object_name: pancreatic neoplasm


subject: PR:000002995

object_name: exocrine pancreatic carcinoma


subject: PR:000002995

object_name: malignant pancreatic neoplasm


subject: UMLS:C5238987

object_name: Non-small cell lung cancer stage III


subject: UNII:4B33BGI082

subject_name: Cholestyramine

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:4B33BGI082

object_name: Unresectable Pancreatic Ductal Adenocarcinoma


subject: UNII:4B33BGI082

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UNII:4B33BGI082

object_name: Advanced Pancreatic Adenocarcinoma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:6402

subject_name: Leflunomide


subject: CHEBI:6402


subject: CHEBI:6402


subject: CHEBI:6402


subject: PUBCHEM.COMPOUND:71306

subject_name: vapreotide

object_name: portal hypertension


subject: PUBCHEM.COMPOUND:71306

object_name: Portal Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:71306

object_name: Esophageal bleeding


subject: PUBCHEM.COMPOUND:71306

object_name: Gastric varix


subject: PUBCHEM.COMPOUND:71306

object_name: esophageal varices


subject: UMLS:C0072994


subject: UMLS:C0072994


subject: UMLS:C0072994


subject: UMLS:C0072994


subject: UMLS:C0072994


subject: RXCUI:215256

subject_name: Anacin

object_name: hereditary endocrine growth disease


subject: UMLS:C1508746

subject_name: egg extract


subject: DRUGBANK:DB10529

subject_name: Egg


subject: CHEBI:3001

subject_name: beclomethasone

object_name: Atopic rhinitis


subject: CHEBI:3001

object_name: Hay fever


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: colorectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UMLS:C0770612

subject_name: licorice root extract

object_name: prostate carcinoma


subject: UMLS:C0770612

object_name: prostate cancer


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: autoimmune hepatitis


subject: CHEBI:6888

object_name: primary biliary cholangitis


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:52172

subject_name: Nilotinib

object_name: Leukemia, Myeloid, Chronic-Phase


subject: PUBCHEM.COMPOUND:34058

subject_name: Gallium citrate

object_name: diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:34058

object_name: Burkitt lymphoma


subject: PUBCHEM.COMPOUND:34058

object_name: Childhood Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:34058

object_name: Adult Burkitt Lymphoma


subject: UNII:HT6C49L0ZP


subject: UNII:HT6C49L0ZP


subject: UNII:HT6C49L0ZP


subject: UNII:HT6C49L0ZP


subject: CHEMBL.COMPOUND:CHEMBL2110553

subject_name: GALLIUM CITRATE


subject: CHEMBL.COMPOUND:CHEMBL2110553


subject: CHEMBL.COMPOUND:CHEMBL2110553


subject: CHEMBL.COMPOUND:CHEMBL2110553


subject: UMLS:C0772142

subject_name: clemizole HCl

object_name: Lennox-Gastaut syndrome


subject: PUBCHEM.COMPOUND:44363234

subject_name: INULINE

object_name: irritable bowel syndrome


subject: CHEBI:16822

subject_name: choline sulfate


subject: CHEBI:15354

subject_name: Choline


subject: CHEBI:9144

subject_name: Silibinin


subject: CHEBI:125451

subject_name: silymarin


subject: CHEBI:4315

subject_name: Danazol

object_name: telomere syndrome


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: multiple system atrophy


subject: CHEBI:15927

object_name: corticobasal syndrome


subject: CHEBI:15927

object_name: corticobasal degeneration disorder


subject: CHEBI:15927

object_name: progressive supranuclear palsy


subject: UNII:U2I8T43Y7R

subject_name: axicabtagene ciloleucel

object_name: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: GTOPDB:11097

subject_name: efineptakin alfa

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: GTOPDB:11097

object_name: Diffuse large B-cell lymphoma recurrent


subject: GTOPDB:11097

object_name: High grade B-cell lymphoma refractory


subject: GTOPDB:11097


subject: GTOPDB:11097

object_name: Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4594590

subject_name: EFINEPTAKIN ALFA


subject: CHEMBL.COMPOUND:CHEMBL4594590


subject: CHEMBL.COMPOUND:CHEMBL4594590


subject: CHEMBL.COMPOUND:CHEMBL4594590


subject: CHEMBL.COMPOUND:CHEMBL4594590


subject: UMLS:C3714111


subject: UMLS:C3714111


subject: UMLS:C3714111


subject: UMLS:C3714111


subject: UMLS:C3714111


subject: DRUGBANK:DB16582

subject_name: Lisocabtagene maraleucel


subject: DRUGBANK:DB16582


subject: DRUGBANK:DB16582


subject: DRUGBANK:DB16582


subject: DRUGBANK:DB16582


subject: UNII:Q6C9WHR03O

subject_name: tisagenlecleucel


subject: UNII:Q6C9WHR03O


subject: UNII:Q6C9WHR03O


subject: UNII:Q6C9WHR03O


subject: UNII:Q6C9WHR03O


subject: UMLS:C2703095

object_name: cancer


subject: UMLS:C2703095

object_name: neoplasm


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: UMLS:C5206245

subject_name: ITK Inhibitor CPI-818

object_name: T-Cell Lymphoma


subject: UMLS:C5206245

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: Testosterone deficiency


subject: CHEBI:84094

object_name: Testosterone Deficiency, CTCAE


subject: CHEBI:84094

object_name: hypogonadism, male


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:10110

subject_name: Zidovudine

object_name: malnutrition


subject: CHEBI:10110

object_name: Human Immunodeficiency Virus Positive


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:63577


subject: CHEBI:31781

subject_name: Lopinavir


subject: CHEBI:31781


subject: CHEBI:63940

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:63940

object_name: obesity


subject: CHEBI:63940

object_name: Obesity, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL85943

subject_name: SODIUM TUNGSTATE


subject: CHEMBL.COMPOUND:CHEMBL85943


subject: CHEMBL.COMPOUND:CHEMBL85943


subject: UMLS:C2830125

object_name: gallbladder carcinoma


subject: UMLS:C2830125

object_name: carcinoma of biliary tract


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C2346810

object_name: Childhood Breast Carcinoma


subject: UMLS:C2346810

object_name: breast carcinoma


subject: UMLS:C2346810

object_name: breast cancer


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: small intestine cancer


subject: UNII:16VY3TM7ZO

object_name: small intestine carcinoma


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721487


subject: UMLS:C4721495

subject_name: Astugenal


subject: UMLS:C4721495


subject: CHEBI:61606

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:61606

object_name: metabolic syndrome X


subject: PUBCHEM.COMPOUND:53477767

subject_name: Hesperidin


subject: PUBCHEM.COMPOUND:53477767


subject: PUBCHEM.COMPOUND:72728820

subject_name: Moxidectin

object_name: scabies


subject: PUBCHEM.COMPOUND:72728820

object_name: hookworm infectious disease


subject: PUBCHEM.COMPOUND:72728820

object_name: ascariasis


subject: PUBCHEM.COMPOUND:72728820

object_name: Infection by Ascaris lumbricoides


subject: PUBCHEM.COMPOUND:72728820

object_name: trichuriasis


subject: PUBCHEM.COMPOUND:53397745

subject_name: Milbemycin A4


subject: PUBCHEM.COMPOUND:53397745


subject: PUBCHEM.COMPOUND:53397745


subject: PUBCHEM.COMPOUND:53397745


subject: PUBCHEM.COMPOUND:53397745


subject: PUBCHEM.COMPOUND:57369871

subject_name: Milbemycin D


subject: PUBCHEM.COMPOUND:57369871


subject: PUBCHEM.COMPOUND:57369871


subject: PUBCHEM.COMPOUND:57369871


subject: PUBCHEM.COMPOUND:57369871


subject: PUBCHEM.COMPOUND:9848354

subject_name: Qsymia

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:9848354

object_name: obesity


subject: PUBCHEM.COMPOUND:9848354

object_name: Obesity, CTCAE


subject: CHEBI:6437

subject_name: Levetiracetam

object_name: generalized epilepsy


subject: CHEBI:6437

object_name: idiopathic generalized epilepsy


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: retinoblastoma


subject: CHEBI:4026

object_name: Gastrointestinal Carcinoid Tumor


subject: CHEBI:4026

object_name: adrenal carcinoma


subject: CHEBI:4026

object_name: adrenal cortex carcinoma


subject: CHEBI:4026

object_name: renal carcinoma


subject: CHEBI:4026

object_name: kidney neoplasm


subject: CHEBI:4026

object_name: kidney cancer


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Pain in female genitalia on intercourse


subject: CHEBI:6456

object_name: Dyspareunia


subject: CHEBI:6456

object_name: Dyspareunia, CTCAE


subject: CHEBI:6456

object_name: Painful intercourse female


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: endometrial cancer


subject: CHEBI:85994

object_name: uterine corpus cancer


subject: CHEBI:85994

object_name: endometrial carcinoma


subject: CHEBI:85994

object_name: Mismatch Repair Proficient


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Recurrent Endometrial Cancer


subject: UNII:DPT0O3T46P


subject: CHEBI:4975

subject_name: Famotidine

object_name: HIV infection


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: Cerebral venous thrombosis


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:68573

subject_name: indacaterol maleate

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:68573

object_name: COPD, severe early onset


subject: CHEBI:135515

subject_name: Bendamustine

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:135515

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:135515

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:135515

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:135515

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:135515


subject: CHEBI:135515

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:135515

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:135515

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: isolated short stature


subject: UNII:NQX9KB6PCL

object_name: Idiopathic short stature


subject: UNII:NQX9KB6PCL

object_name: hereditary endocrine growth disease


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Treatment related secondary malignancy


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: CHEBI:74698

subject_name: Met-Arg

object_name: Overweight and obesity


subject: CHEBI:74698

object_name: Dyslipoproteinemias


subject: PR:000011407

subject_name: mineralocorticoid receptor


subject: PR:000011407


subject: UNII:6VAD9SC8NW

object_name: Compulsion


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: juvenile dermatomyositis


subject: UNII:4F4X42SYQ6

object_name: polymyositis


subject: UNII:4F4X42SYQ6

object_name: myositis


subject: UNII:4F4X42SYQ6

object_name: Myositis, CTCAE 5.0


subject: UNII:4F4X42SYQ6

object_name: adult dermatomyositis


subject: UNII:4F4X42SYQ6

object_name: dermatomyositis


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:8452

subject_name: Proflavine

object_name: uterine cancer


subject: CHEBI:8452

object_name: tumor of uterus


subject: UNII:L33EX3XR0T

object_name: COPD, severe early onset


subject: UNII:L33EX3XR0T

object_name: chronic obstructive pulmonary disease


subject: UMLS:C3713989


subject: UMLS:C3713989


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: fibromyalgia


subject: CHEBI:9907

subject_name: ursodiol

object_name: cholecystolithiasis


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Single Ventricle Defect


subject: CHEBI:9241

object_name: Single ventricle


subject: UNII:8L7891MRB6

subject_name: Encorafenib

object_name: Hepatic impairment


subject: UNII:8L7891MRB6

object_name: metastatic melanoma


subject: UNII:8L7891MRB6

object_name: Unresectable Melanoma


subject: CHEBI:145371

subject_name: Binimetinib


subject: CHEBI:145371


subject: CHEBI:145371


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: diabetic macular edema


subject: CHEBI:149509

object_name: atrial fibrillation


subject: CHEBI:149509

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:149509

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:3347


subject: CHEBI:3347


subject: DRUGBANK:DB16582

subject_name: Lisocabtagene maraleucel

object_name: adult lymphoma


subject: DRUGBANK:DB16582

object_name: lymphoma


subject: DRUGBANK:DB16582

object_name: pediatric lymphoma


subject: DRUGBANK:DB16582

object_name: lymphoma, non-Hodgkin, familial


subject: DRUGBANK:DB16582

object_name: non-Hodgkin lymphoma


subject: DRUGBANK:DB16582

object_name: B-cell neoplasm


subject: DRUGBANK:DB16582

object_name: lymphoproliferative syndrome


subject: DRUGBANK:DB16582

object_name: immunoproliferative disorder


subject: DRUGBANK:DB16582

object_name: immune system disorder


subject: DRUGBANK:DB16582

object_name: Neoplasms by Histologic Type


subject: DRUGBANK:DB16582

object_name: lymphoid system disorder


subject: DRUGBANK:DB16582

object_name: Lymphadenopathy


subject: DRUGBANK:DB16582

object_name: neoplasm


subject: CHEBI:6933

subject_name: Midodrine

object_name: Blood Pressure Finding


subject: CHEBI:6933

object_name: Systemic arterial pressure


subject: CHEBI:6933

object_name: Hypotensive


subject: CHEBI:6933

object_name: Cerebral Blood Flow


subject: CHEBI:6933

object_name: autonomic dysreflexia


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron


subject: PUBCHEM.COMPOUND:18319735


subject: PUBCHEM.COMPOUND:18319735


subject: PUBCHEM.COMPOUND:18319735

object_name: spinal cord injury


subject: PUBCHEM.COMPOUND:18319735


subject: PUBCHEM.COMPOUND:18319735


subject: CHEBI:8665

subject_name: Pyridostigmine


subject: CHEBI:8665


subject: CHEBI:8665


subject: CHEBI:8665


subject: CHEBI:8665


subject: CHEBI:8665


subject: CHEBI:60799

subject_name: Esketamine

object_name: Postoperative depression


subject: CHEBI:85078

object_name: hypertension


subject: CHEBI:85078

object_name: Hypertension, CTCAE


subject: CHEBI:9434

subject_name: Telmisartan

object_name: type 2 diabetes mellitus


subject: UMLS:C2698199

subject_name: Lovaxin-C

object_name: Cervix carcinoma recurrent


subject: UMLS:C2698199

object_name: Cervical Squamous Cell Carcinoma, Not Otherwise Specified


subject: CHEBI:231369

subject_name: Savolitinib

object_name: Stomach cancer


subject: CHEBI:231369

object_name: gastric cancer


subject: CHEBI:231369

object_name: esophagogastric junction disorder


subject: CHEBI:75998

subject_name: Trametinib

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:75998

object_name: amyotrophic lateral sclerosis


subject: UMLS:C4287784

object_name: ovarian cancer


subject: UMLS:C4287784

object_name: ovarian neoplasm


subject: UMLS:C4287784

object_name: ovarian carcinoma


subject: UMLS:C4287784

object_name: cancer


subject: UMLS:C4287784

object_name: neoplasm


subject: UMLS:C4287784

object_name: Recurrent ovarian cancer


subject: UMLS:C4287784

object_name: female reproductive organ cancer


subject: CHEBI:84040

object_name: type 1 diabetes mellitus


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: neuroendocrine carcinoma


subject: UNII:P0GVQ9A4S5

object_name: small cell lung carcinoma


subject: UNII:P0GVQ9A4S5

object_name: Stage III Lung Cancer AJCC v8


subject: UNII:P0GVQ9A4S5

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UNII:P0GVQ9A4S5

object_name: Stage IIIA Lung Cancer AJCC v8


subject: UNII:P0GVQ9A4S5

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: UMLS:C5432262

subject_name: zansecimab

object_name: Solid Neoplasm


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UMLS:C1721684

subject_name: lexatumumab


subject: CHEBI:6456

subject_name: Lidocaine

object_name: prostate carcinoma


subject: CHEBI:6456

object_name: prostate cancer


subject: CHEBI:9316

subject_name: Sufentanil


subject: CHEBI:9316


subject: UNII:3M6325NY1R

subject_name: Iron isomaltoside 1000

object_name: chronic kidney disease


subject: UNII:3M6325NY1R

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:3M6325NY1R

object_name: iron deficiency anemia


subject: UNII:AHU547PI9H

subject_name: Ferric derisomaltose


subject: UNII:AHU547PI9H


subject: CHEBI:17824

subject_name: isopropanol

object_name: Primary malignant neoplasm


subject: CHEBI:17824

object_name: cancer


subject: CHEBI:17824

object_name: childhood malignant neoplasm


subject: CHEBI:17824

object_name: Malignant obstetric neoplasm


subject: CHEBI:147155

object_name: ulcerative colitis


subject: CHEBI:147155

object_name: inflammatory bowel disease 1


subject: CHEBI:147155

object_name: Crohn disease


subject: CHEBI:147155

object_name: inflammatory bowel disease


subject: CHEBI:62263


subject: CHEBI:62263


subject: CHEBI:62263


subject: CHEBI:62263


subject: CHEBI:17688

subject_name: Nicotine

object_name: drug dependence


subject: GTOPDB:4934

subject_name: G-CSF

object_name: Carcinoma breast stage IV


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PUBCHEM.COMPOUND:44398718

subject_name: CCP


subject: UMLS:C1525410

subject_name: Cyclic citrullinated peptide antibody


subject: UMLS:C5417945

object_name: Childhood Breast Carcinoma


subject: UMLS:C5417945

object_name: breast carcinoma


subject: UMLS:C5417945

object_name: breast cancer


subject: UMLS:C5417945

object_name: Childhood Solid Neoplasm


subject: UMLS:C5417945

object_name: Adult Solid Neoplasm


subject: UMLS:C5417945

object_name: Solid Neoplasm


subject: CHEBI:2659

subject_name: Aminophylline

object_name: acute kidney failure


subject: CHEBI:2659

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:28177

subject_name: Theophylline


subject: CHEBI:28177


subject: CHEBI:4672

subject_name: Docetaxel

object_name: kidney neoplasm


subject: CHEBI:177609

subject_name: Tariquidar

object_name: ovarian cancer


subject: CHEBI:177609

object_name: ovarian neoplasm


subject: CHEBI:177609


subject: CHEBI:177609

object_name: lung neoplasm


subject: CHEBI:177609

object_name: cervical polyp


subject: UNII:L7K247H29H

object_name: HIV infection


subject: DRUGBANK:DB06496

subject_name: Dextrin 2-sulfate


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026

object_name: myelodysplastic syndrome with excess blasts


subject: CHEBI:4026

object_name: childhood acute megakaryoblastic leukemia


subject: CHEBI:4026

object_name: acute megakaryoblastic leukemia


subject: CHEBI:4026

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:4026

object_name: Childhood Acute Erythroid Leukemia


subject: CHEBI:4026

object_name: erythroleukemia


subject: CHEBI:4026

object_name: Adult Acute Erythroid Leukemia


subject: CHEBI:4026

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: CHEBI:4026

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEMBL.COMPOUND:CHEMBL4297239

subject_name: DILANUBICEL


subject: CHEMBL.COMPOUND:CHEMBL4297239

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEMBL.COMPOUND:CHEMBL4297239

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297239

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEMBL.COMPOUND:CHEMBL4297239


subject: CHEMBL.COMPOUND:CHEMBL4297239


subject: CHEMBL.COMPOUND:CHEMBL4297239


subject: CHEMBL.COMPOUND:CHEMBL4297239


subject: CHEMBL.COMPOUND:CHEMBL4297239

object_name: acute lymphoblastic leukemia


subject: CHEMBL.COMPOUND:CHEMBL4297239

object_name: Myelodysplasia


subject: CHEMBL.COMPOUND:CHEMBL4297239

object_name: Adult Myelodysplastic Syndrome


subject: CHEMBL.COMPOUND:CHEMBL4297239

object_name: childhood myelodysplastic syndrome


subject: CHEMBL.COMPOUND:CHEMBL4297239

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL4297239


subject: CHEMBL.COMPOUND:CHEMBL4297239


subject: CHEMBL.COMPOUND:CHEMBL4297239


subject: CHEMBL.COMPOUND:CHEMBL4297239

object_name: acute myeloid leukemia by FAB classification


subject: CHEMBL.COMPOUND:CHEMBL4297239

object_name: acute myeloid leukemia


subject: CHEMBL.COMPOUND:CHEMBL4297239


subject: CHEMBL.COMPOUND:CHEMBL4297239


subject: CHEMBL.COMPOUND:CHEMBL4297239

object_name: lymphoma, non-Hodgkin, familial


subject: CHEMBL.COMPOUND:CHEMBL4297239

object_name: non-Hodgkin lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4297239

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4297239

object_name: Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: HIV infection


subject: PUBCHEM.COMPOUND:3367

object_name: myelodysplastic syndrome with excess blasts


subject: PUBCHEM.COMPOUND:3367

object_name: childhood acute megakaryoblastic leukemia


subject: PUBCHEM.COMPOUND:3367

object_name: acute megakaryoblastic leukemia


subject: PUBCHEM.COMPOUND:3367

object_name: acute megakaryoblastic leukemia in adult


subject: PUBCHEM.COMPOUND:3367

object_name: Childhood Acute Erythroid Leukemia


subject: PUBCHEM.COMPOUND:3367

object_name: erythroleukemia


subject: PUBCHEM.COMPOUND:3367

object_name: Adult Acute Erythroid Leukemia


subject: PUBCHEM.COMPOUND:3367

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: PUBCHEM.COMPOUND:3367

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: UNII:XX2MN88N5D

subject_name: Efalizumab

object_name: psoriasis


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Immune Tolerance


subject: CHEBI:9130

object_name: Drug Tolerance


subject: UMLS:C5814627

object_name: mucopolysaccharidosis type 3B


subject: UMLS:C5139660

subject_name: Lesinidase alfa


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: pancreatic neoplasm


subject: MESH:C520255

object_name: exocrine pancreatic carcinoma


subject: MESH:C520255

object_name: malignant pancreatic neoplasm


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: lupus nephritis


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UNII:73B0K5S26A

subject_name: Belimumab


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:8382

subject_name: Prednisone


subject: DRUGBANK:DB16480

object_name: Childhood Solid Neoplasm


subject: DRUGBANK:DB16480

object_name: Adult Solid Neoplasm


subject: DRUGBANK:DB16480

object_name: Solid Neoplasm


subject: UMLS:C5964773

subject_name: Toll-like Receptor 7/8 Agonist EIK1001


subject: UMLS:C5964773


subject: UMLS:C5964773


subject: PUBCHEM.COMPOUND:343523

object_name: medullary thyroid gland carcinoma


subject: PUBCHEM.COMPOUND:343523

object_name: carcinoid tumor


subject: PUBCHEM.COMPOUND:343523

object_name: neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:343523

object_name: digestive system neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:343523

object_name: Childhood Neuroblastoma


subject: PUBCHEM.COMPOUND:343523

object_name: neuroblastoma


subject: PUBCHEM.COMPOUND:343523

object_name: adrenal gland pheochromocytoma


subject: PUBCHEM.COMPOUND:343523

object_name: pheochromocytoma


subject: PUBCHEM.COMPOUND:343523

object_name: paraganglioma


subject: PUBCHEM.COMPOUND:343523

object_name: insulinoma


subject: CHEBI:49166

subject_name: fluorodopa F 18


subject: CHEBI:49166


subject: CHEBI:49166


subject: CHEBI:49166


subject: CHEBI:49166


subject: CHEBI:49166


subject: CHEBI:49166


subject: CHEBI:49166


subject: CHEBI:49166


subject: CHEBI:53233

subject_name: thiazolyl blue

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:53233

object_name: pulmonary hypertension


subject: CHEBI:53233

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:53233

object_name: pulmonary arterial hypertension


subject: PUBCHEM.COMPOUND:131613


subject: PUBCHEM.COMPOUND:131613


subject: PUBCHEM.COMPOUND:131613


subject: PUBCHEM.COMPOUND:131613


subject: CHEBI:3764

subject_name: Clotrimazole

object_name: otomycosis


subject: CHEBI:185135

subject_name: Polyvidone


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: UMLS:C2987384

subject_name: BMN 673

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C2987384

object_name: Embolism, Tumor


subject: UMLS:C2987384

object_name: Neoplasm Metastasis


subject: UMLS:C2987384

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: UMLS:C0392939

subject_name: recombinant human thrombopoietin

object_name: thrombocytopenia


subject: UMLS:C0392939

object_name: autoimmune thrombocytopenia


subject: UMLS:C0392939

object_name: thrombocytopenia due to immune destruction


subject: UMLS:C0392939

object_name: autoimmune thrombocytopenic purpura


subject: MESH:C000589718

object_name: lactose intolerance


subject: UNII:W248Y1AKOR

subject_name: Tovinontrine

object_name: heart failure


subject: UNII:W248Y1AKOR

object_name: Heart Failure, CTCAE


subject: UNII:W248Y1AKOR

object_name: Heart failure with reduced ejection fraction


subject: UNII:W248Y1AKOR

object_name: heart disorder


subject: UNII:W248Y1AKOR

object_name: cardiovascular disorder


subject: CHEBI:31215

subject_name: anecortave

object_name: macular degeneration


subject: CHEBI:31215

object_name: age-related macular degeneration


subject: CHEBI:31215

object_name: retinitis pigmentosa 30


subject: CHEBI:74705

subject_name: Met-Leu


subject: CHEBI:74705


subject: CHEBI:74705


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PUBCHEM.COMPOUND:156612993

subject_name: Murepavadin

object_name: pneumonia


subject: PUBCHEM.COMPOUND:156612993

object_name: COVID-19-Associated Pneumonia


subject: UMLS:C5139728

subject_name: murepavadin


subject: UMLS:C5139728


subject: CHEBI:51450

subject_name: Bosentan

object_name: hypertension


subject: CHEBI:51450

object_name: Hypertension, CTCAE


subject: UMLS:C0919079

object_name: brain cancer


subject: CHEBI:72564


subject: CHEBI:2955

subject_name: Azithromycin

object_name: Vaginal dysbiosis


subject: CHEBI:2955

object_name: bacterial vaginosis


subject: CHEBI:2955

object_name: Premature Delivery, CTCAE


subject: CHEBI:2955

object_name: History of - premature delivery


subject: CHEBI:29007

subject_name: Ceftriaxone


subject: CHEBI:29007


subject: CHEBI:29007


subject: CHEBI:29007

object_name: Premature birth


subject: CHEBI:29007


subject: CHEBI:3764

subject_name: Clotrimazole


subject: CHEBI:3764


subject: CHEBI:3764


subject: CHEBI:3764


subject: CHEBI:3764


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: UNII:79R3ZF226Y

object_name: acne


subject: CHEBI:53228


subject: CHEBI:60622


subject: UMLS:C5239340

subject_name: Nanoparticle-based Manganese-containing Contrast Agent SN132D

object_name: Childhood Breast Carcinoma


subject: UMLS:C5239340

object_name: breast carcinoma


subject: UMLS:C5239340

object_name: breast cancer


subject: UMLS:C5239340

object_name: pancreatic neoplasm


subject: UMLS:C5239340

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5239340

object_name: malignant pancreatic neoplasm


subject: CHEBI:63450

subject_name: Masitinib

object_name: indolent systemic mastocytosis


subject: CHEBI:177413

subject_name: Plinabulin

object_name: Advanced Melanoma


subject: CHEBI:177413

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:177413

object_name: Advanced Merkel Cell Carcinoma


subject: CHEBI:177413

object_name: Advanced renal cell carcinoma


subject: CHEBI:177413

object_name: Advanced Bladder Carcinoma


subject: CHEBI:177413

object_name: Advanced Lung Non-Small Cell Carcinoma


subject: CHEBI:177413

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:177413

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:177413

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:177413

object_name: Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8


subject: CHEBI:177413

object_name: Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8


subject: CHEBI:177413

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:177413

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:177413

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:177413

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:177413

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:177413

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:177413

object_name: Stage IV Bladder Cancer AJCC v8


subject: CHEBI:177413

object_name: Stage IIIA Bladder Cancer AJCC v8


subject: CHEBI:177413

object_name: Stage IIIB Bladder Cancer AJCC v8


subject: CHEBI:177413

object_name: Stage IVA Bladder Cancer AJCC v8


subject: CHEBI:177413

object_name: Stage IVB Bladder Cancer AJCC v8


subject: CHEBI:177413

object_name: Stage III Bladder Cancer AJCC v8


subject: CHEBI:177413

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:177413

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:177413

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:177413

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:177413

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:177413

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:177413

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:177413

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: UMLS:C1741609

object_name: Advanced Melanoma


subject: UMLS:C1741609

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C1741609

object_name: Advanced Merkel Cell Carcinoma


subject: UMLS:C1741609

object_name: Advanced renal cell carcinoma


subject: UMLS:C1741609

object_name: Advanced Bladder Carcinoma


subject: UMLS:C1741609

object_name: Advanced Lung Non-Small Cell Carcinoma


subject: UMLS:C1741609

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C1741609

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UMLS:C1741609

object_name: Stage IV Lung Cancer AJCC v8


subject: UMLS:C1741609

object_name: Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8


subject: UMLS:C1741609

object_name: Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8


subject: UMLS:C1741609

object_name: Stage IVA Lung Cancer AJCC v8


subject: UMLS:C1741609

object_name: Stage III Lung Cancer AJCC v8


subject: UMLS:C1741609

object_name: Stage IVB Lung Cancer AJCC v8


subject: UMLS:C1741609

object_name: Stage IIIA Lung Cancer AJCC v8


subject: UMLS:C1741609

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UMLS:C1741609

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UMLS:C1741609

object_name: Stage IV Bladder Cancer AJCC v8


subject: UMLS:C1741609

object_name: Stage IIIA Bladder Cancer AJCC v8


subject: UMLS:C1741609

object_name: Stage IIIB Bladder Cancer AJCC v8


subject: UMLS:C1741609

object_name: Stage IVA Bladder Cancer AJCC v8


subject: UMLS:C1741609

object_name: Stage IVB Bladder Cancer AJCC v8


subject: UMLS:C1741609

object_name: Stage III Bladder Cancer AJCC v8


subject: UMLS:C1741609

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: UMLS:C1741609

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: UMLS:C1741609

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: UMLS:C1741609

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: UMLS:C1741609

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: UMLS:C1741609

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: UMLS:C1741609

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: UMLS:C1741609

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate

object_name: Refractory acute myeloid leukemia


subject: PUBCHEM.COMPOUND:16760419

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:4911

subject_name: Etoposide


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: UMLS:C3540703

subject_name: ANTIANDROGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM

object_name: prostate carcinoma


subject: UMLS:C3540703

object_name: prostate cancer


subject: CHEBI:35497

subject_name: androgen antagonist


subject: CHEBI:35497


subject: UMLS:C0002842

subject_name: Androgen Antagonists


subject: UMLS:C0002842


subject: CHEBI:64212

subject_name: Exisulind


subject: CHEBI:64212


subject: UMLS:C2987634

subject_name: Agonist


subject: UMLS:C2987634


subject: UNII:TC549UFL8P

object_name: Abdominal obesity


subject: UNII:TC549UFL8P

object_name: obesity


subject: UMLS:C1831848


subject: UMLS:C1831848


subject: CHEBI:4893

subject_name: ethyl acetoacetate

object_name: Sarcopenic obesity


subject: UMLS:C0243046

subject_name: Excitatory Amino Acids


subject: CHEBI:30956

subject_name: trichloroacetic acid


subject: UMLS:C3536819

subject_name: Tricyclic Antidepressant [EPC]


subject: CHEBI:36080

subject_name: protein


subject: UMLS:C0033684

subject_name: Proteins


subject: PR:000000001


subject: CHEBI:66910

subject_name: Axitinib

object_name: Clear-cell metastatic renal cell carcinoma


subject: GTOPDB:13785

subject_name: stapokibart

object_name: poikiloderma with neutropenia


subject: GTOPDB:13785

object_name: prurigo nodularis


subject: CHEMBL.COMPOUND:CHEMBL5095324

subject_name: STAPOKIBART


subject: CHEMBL.COMPOUND:CHEMBL5095324


subject: UMLS:C5706513

subject_name: Stapokibart


subject: UMLS:C5706513


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: trabecular adenocarcinoma


subject: UNII:KXG2PJ551I

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C5417780

subject_name: KRT 232


subject: UMLS:C5417780


subject: CHEBI:49668

subject_name: Gefitinib

object_name: adult glioblastoma


subject: CHEBI:49668

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:49668

object_name: Adult Gliosarcoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: cervical squamous cell carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Cervix carcinoma recurrent


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: deafness


subject: CHEBI:41879

object_name: hearing loss by exam


subject: CHEBI:91834

subject_name: Articaine

object_name: pulpitis


subject: CHEBI:28918

subject_name: Epinephrine


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib

object_name: Metastatic human epidermal growth factor 2 positive carcinoma of breast


subject: CHEBI:31348

subject_name: Capecitabine


subject: UMLS:C0972569

subject_name: Electrophoresis Gel

object_name: Traumatic Wound


subject: UMLS:C0972569

object_name: Injury


subject: UMLS:C0972569

object_name: Wounds and Injuries


subject: UMLS:C0972569

object_name: decubitus ulcer


subject: UMLS:C1382104

subject_name: Gel physical state


subject: UMLS:C1382104


subject: UMLS:C1382104


subject: UMLS:C1382104


subject: UMLS:C1551386

subject_name: Gel - ContainerSeparator


subject: UMLS:C1551386


subject: UMLS:C1551386


subject: UMLS:C1551386


subject: UMLS:C0876066

subject_name: Levulan Kerastick

object_name: squamous cell carcinoma


subject: CHEBI:17549

subject_name: Aminolevulinic acid


subject: UNII:5YV419FIJS

subject_name: sodium glycididazole

object_name: triple-negative breast carcinoma


subject: UNII:5YV419FIJS

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:74814

subject_name: Ser-Gly


subject: CHEBI:74814


subject: CHEBI:33351

subject_name: seaborgium atom


subject: CHEBI:33351


subject: CHEBI:59773

subject_name: CROMOLYN

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:59773

object_name: viral pneumonia


subject: CHEBI:59773

object_name: COVID-19 respiratory infection


subject: CHEBI:45783

subject_name: Imatinib

object_name: acute lymphoblastic leukemia


subject: UNII:621XR2W6OP

subject_name: Methylprednisone


subject: PUBCHEM.COMPOUND:5126752


subject: CHEBI:135573

subject_name: Meprednisone


subject: UNII:1351PE5UGS

subject_name: Elotuzumab

object_name: Plasma cell myeloma recurrent


subject: PUBCHEM.COMPOUND:53328043

subject_name: Iberdomide


subject: UMLS:C5785377

subject_name: Engineered IL-12 Prodrug WTX-330

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5785377

object_name: non-Hodgkin lymphoma


subject: UMLS:C5785377

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C5785377

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Night Eating Syndrome


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: Post measles pneumonia


subject: CHEBI:3770

object_name: measles


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: mucositis


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Progression of rheumatoid arthritis


subject: CHEMBL.COMPOUND:CHEMBL2109402

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL2109402

object_name: colorectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109402

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL2109402

object_name: head and neck squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109402

object_name: non-small cell lung carcinoma


subject: UMLS:C2703144


subject: UMLS:C2703144


subject: UMLS:C2703144


subject: UMLS:C2703144


subject: UMLS:C2703144


subject: UMLS:C3641662


subject: UMLS:C3641662


subject: UMLS:C3641662


subject: UMLS:C3641662


subject: UMLS:C3641662


subject: GTOPDB:9125


subject: GTOPDB:9125


subject: UMLS:C3275035


subject: UMLS:C3275035


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: nephrolithiasis


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:73604

object_name: urinary tract infection


subject: CHEBI:73604

object_name: Sepsis


subject: CHEBI:73604

object_name: Sepsis, CTCAE


subject: CHEBI:184472

subject_name: Nitrofurantoin


subject: CHEBI:184472


subject: CHEBI:184472


subject: CHEBI:63632

subject_name: Topotecan

object_name: unspecified adult solid tumor, protocol specific


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Childhood Neuroblastoma


subject: GTOPDB:12990

object_name: neuroblastoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: Bronchospasm


subject: CHEBI:132922

object_name: Low back pain


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:59224

subject_name: Cetrorelix

object_name: Androgen excess


subject: CHEBI:59224

object_name: Encounter due to In vitro fertilization


subject: CHEBI:95043

object_name: prostate carcinoma


subject: CHEBI:95043

object_name: prostate cancer


subject: PR:000004912

subject_name: vertebrate-type carbonic anhydrase 1

object_name: HIV infection


subject: PR:000007007

subject_name: eukaryotic translation initiation factor 6


subject: CHEBI:73527

subject_name: Leu-Ala


subject: CHEBI:33336

subject_name: lanthanum atom


subject: CHEBI:17351

subject_name: Linoleic acid


subject: UMLS:C0148199

subject_name: Vascular Endothelial Growth Factor Receptor

object_name: triple-negative breast carcinoma


subject: UMLS:C0148199

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:31348

subject_name: Capecitabine


subject: UMLS:C3712108

object_name: hepatitis C


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Childhood Breast Carcinoma


subject: CHEBI:93775

object_name: breast carcinoma


subject: CHEBI:93775

object_name: breast cancer


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:38940


subject: CHEBI:38940


subject: DRUGBANK:DB06063

object_name: acromegaly


subject: DRUGBANK:DB06063

object_name: Acral overgrowth


subject: CHEBI:9241

subject_name: Spironolactone

object_name: acute kidney failure


subject: CHEBI:9241

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:9241

object_name: myocardial ischemia


subject: CHEBI:9241

object_name: contrast-induced nephropathy


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: adult liposarcoma


subject: CHEBI:175901

object_name: liposarcoma


subject: CHEBI:175901

object_name: pediatric liposarcoma


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN


subject: PUBCHEM.COMPOUND:49865963


subject: PUBCHEM.COMPOUND:49865963


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: UMLS:C5222496

subject_name: Repository Corticotropin Injection

object_name: xerophthalmia


subject: UMLS:C5222496

object_name: dry eye syndrome


subject: PUBCHEM.COMPOUND:78092786

subject_name: Etelcalcetide

object_name: Vascular calcification


subject: PUBCHEM.COMPOUND:78092786

object_name: secondary hyperparathyroidism of renal origin


subject: PUBCHEM.COMPOUND:78092786

object_name: Renal rickets


subject: UMLS:C3712398


subject: UMLS:C3712398


subject: UMLS:C3712398


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: ovarian cancer


subject: CHEBI:63791

object_name: ovarian neoplasm


subject: CHEBI:63791

object_name: ovarian carcinoma


subject: CHEBI:63791

object_name: malignant epithelial tumor of ovary


subject: CHEBI:63791

object_name: primary peritoneal carcinoma


subject: CHEBI:63791

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:63791

object_name: peritoneal carcinoma


subject: CHEBI:63791

object_name: fallopian tube carcinoma


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:63660

object_name: coronary artery disorder


subject: CHEBI:63660

object_name: Hypercholesterolemia


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:63618


subject: UMLS:C1577331

subject_name: Vitrase

object_name: drug allergy


subject: CHEBI:8988

object_name: non-small cell lung carcinoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:4031

subject_name: Cyclosporine


subject: PUBCHEM.COMPOUND:16131310

subject_name: Hepatitis B Vaccines

object_name: hepatitis A


subject: PUBCHEM.COMPOUND:16131310

object_name: hepatitis


subject: DRUGBANK:DB11627

subject_name: Hepatitis B Vaccine (Recombinant)


subject: DRUGBANK:DB11627


subject: UMLS:C2240392


subject: UMLS:C2240392


subject: UMLS:C0062527

subject_name: Engerix-B


subject: UMLS:C0062527


subject: UMLS:C5565806

object_name: Primary gout


subject: UMLS:C0962969

subject_name: RAD 001

object_name: lung cancer


subject: UMLS:C0962969

object_name: lung neoplasm


subject: UMLS:C0962969

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:50777

subject_name: Etonogestrel

object_name: Uses contraception (finding)


subject: UMLS:C2933615

subject_name: LCZ 696

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:56948407

object_name: herpes zoster


subject: PUBCHEM.COMPOUND:56948407

object_name: postherpetic neuralgia


subject: PUBCHEM.COMPOUND:11511576

subject_name: Tedizolid phosphate

object_name: pneumonia


subject: PUBCHEM.COMPOUND:11511576

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:82717

subject_name: Tedizolid


subject: CHEBI:82717


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: Coronavinae infectious disease


subject: CHEBI:177517

subject_name: Bifeprunox

object_name: schizophrenia


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Childhood Neuroblastoma


subject: UNII:2S9ZZM9Q9V

object_name: neuroblastoma


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Widespread Chronic Pain


subject: CHEBI:66964

subject_name: Dronabinol


subject: UMLS:C1141002

subject_name: prune preparation

object_name: Constipation


subject: UMLS:C1141002

object_name: Constipation, CTCAE


subject: UNII:A17W0640NB

object_name: post-traumatic stress disorder


subject: UNII:A17W0640NB

object_name: BH4-deficient hyperphenylalaninemia A


subject: UMLS:C5205493

subject_name: Pucotenlimab

object_name: liver carcinoma


subject: CHEBI:73508

subject_name: Glu-Pro

object_name: non-small cell lung carcinoma


subject: PR:000006295

subject_name: acyl-CoA-binding protein


subject: PR:000008736

subject_name: BLOC-3 complex member HPS1


subject: PUBCHEM.COMPOUND:126571915

object_name: leishmaniasis


subject: UNII:T7XAE9Y6B9


subject: GTOPDB:4985

object_name: Clear-cell metastatic renal cell carcinoma


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: ovarian carcinoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:31348

subject_name: Capecitabine


subject: DRUGBANK:DB17528

object_name: ovarian cancer


subject: DRUGBANK:DB17528

object_name: ovarian neoplasm


subject: DRUGBANK:DB17528


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17530


subject: DRUGBANK:DB17530


subject: DRUGBANK:DB17530


subject: UMLS:C4758796


subject: UMLS:C4758796


subject: UMLS:C4758796


subject: UNII:B0L24T8TB7


subject: UNII:B0L24T8TB7


subject: UNII:B0L24T8TB7


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: UNII:D87YGH4Z0Q


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Acute non-ST segment elevation myocardial infarction (disorder)


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: Pregnant


subject: UNII:F0GIZ22IJH

subject_name: Reproxalap

object_name: respiratory syncytial virus infectious disease


subject: CHEBI:91899

object_name: long COVID-19


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:5147

subject_name: Formoterol


subject: CHEBI:408174

subject_name: Arformoterol


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: osteoarthritis


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:3757

subject_name: Clonidine


subject: CHEBI:6129

subject_name: Ketorolac


subject: UMLS:C1874000

subject_name: Acetated Ringer's Solution

object_name: benign neoplasm


subject: UMLS:C1874000

object_name: Benign obstetric neoplasm


subject: UMLS:C1874000

object_name: respiratory system benign neoplasm


subject: UMLS:C1874000

object_name: colorectal disorders


subject: UMLS:C1874000

object_name: female reproductive organ cancer


subject: UMLS:C1874000

object_name: malignant urinary system neoplasm


subject: UMLS:C1874000

object_name: colorectal cancer


subject: UMLS:C1874000

object_name: colorectal carcinoma


subject: UMLS:C1874000

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:8892

object_name: type 2 diabetes mellitus


subject: CHEBI:8892

object_name: Insulin resistance


subject: UMLS:C0875967

subject_name: Avandia


subject: UMLS:C0875967


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: PUBCHEM.COMPOUND:11756905

subject_name: Delamanid

object_name: tuberculosis


subject: PUBCHEM.COMPOUND:11756905

object_name: HIV infection


subject: PR:000001875

subject_name: leptin receptor


subject: PR:000001875


subject: PR:000009762

subject_name: leptin receptor gene-related protein


subject: PR:000009762


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Gastrointestinal motility disorder


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:51254

subject_name: AMOXICILLIN


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:135533

subject_name: Talinolol


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Central Nervous System Neoplasms, Primary


subject: CHEBI:63791

subject_name: Lenalidomide


subject: UMLS:C2347055

subject_name: Manuka Honey

object_name: Oral Mucositis


subject: UMLS:C2347055

object_name: stomatitis


subject: UMLS:C2347055

object_name: oral mucositis


subject: UMLS:C2347055

object_name: leukemia


subject: UMLS:C2347055

object_name: childhood leukemia


subject: CHEMBL.COMPOUND:CHEMBL2107910

subject_name: OLIVE OIL


subject: CHEMBL.COMPOUND:CHEMBL2107910


subject: CHEMBL.COMPOUND:CHEMBL2107910


subject: CHEMBL.COMPOUND:CHEMBL2107910


subject: CHEMBL.COMPOUND:CHEMBL2107910


subject: UMLS:C1135124

object_name: prostate carcinoma


subject: UMLS:C1135124

object_name: prostate cancer


subject: CHEBI:15365

subject_name: Aspirin

object_name: aspirin resistance


subject: PUBCHEM.COMPOUND:104747

subject_name: Tegafur-uracil

object_name: oral cavity squamous cell carcinoma


subject: UNII:6N79I7X5II

subject_name: VALEMETOSTAT TOSYLATE

object_name: adult T-cell leukemia/lymphoma


subject: UMLS:C5238968

subject_name: Valemetostat Tosylate


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: neoplastic meningitis


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: CHEBI:176843

subject_name: vitamin B12


subject: UMLS:C0086024

subject_name: cobalamins


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: CHEBI:80345

subject_name: Cholecystokinin

object_name: type 2 diabetes mellitus


subject: UMLS:C4743011

object_name: Autoimmunity


subject: CHEBI:3423

subject_name: Carmustine

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:3423

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:3423

object_name: Prognosis bad


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:41879

object_name: diffuse large B-cell lymphoma


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:8382

subject_name: Prednisone


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: PUBCHEM.COMPOUND:3367

object_name: Unresectable Melanoma


subject: PUBCHEM.COMPOUND:3367

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:3367

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: DRUGBANK:DB17107

subject_name: Lifileucel


subject: DRUGBANK:DB17107


subject: DRUGBANK:DB17107


subject: CHEBI:91327

subject_name: Tivozanib

object_name: cholangiocarcinoma


subject: CHEBI:91327

object_name: bile duct neoplasm


subject: PUBCHEM.COMPOUND:162625103

subject_name: Ecnoglutide


subject: CHEMBL.COMPOUND:CHEMBL5095115

subject_name: ECNOGLUTIDE


subject: CHEBI:49882

subject_name: rhenium atom

object_name: non-small cell lung carcinoma


subject: CHEBI:49882

object_name: Neoplasm Recurrence, Local


subject: CHEBI:49882

object_name: lung neoplasm


subject: CHEBI:49882

object_name: small cell carcinoma


subject: PUBCHEM.COMPOUND:137796979

object_name: kidney failure


subject: PUBCHEM.COMPOUND:90488848

object_name: Androgen excess


subject: CHEBI:3892

subject_name: Corticotropin


subject: UMLS:C0718234

subject_name: Acthar


subject: CHEBI:17925

subject_name: alpha-D-glucose


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: CHEBI:17234

subject_name: D-glucose


subject: UMLS:C0593510

subject_name: Recombinant human follicle stimulating hormone


subject: CHEBI:6801

subject_name: Metformin

object_name: Iatrogenic Cushing's disease


subject: CHEBI:3423

subject_name: Carmustine

object_name: Hodgkin Disease


subject: HMDB:HMDB0256702

subject_name: Porfimer Sodium

object_name: pleural disease


subject: HMDB:HMDB0256702


subject: UNII:Y3834SIK5F

subject_name: PORFIMER SODIUM


subject: UNII:Y3834SIK5F


subject: UNII:B5TRY67L51

object_name: type 1 diabetes mellitus 1


subject: UNII:B5TRY67L51

object_name: type 1 diabetes mellitus


subject: CHEBI:43602

subject_name: Obeticholic acid

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C0388020

subject_name: Gadovist

object_name: Brain Lesion


subject: UMLS:C0753357

subject_name: MultiHance


subject: UNII:DNZ11VPY7Q

object_name: Advanced cancer


subject: UNII:DNZ11VPY7Q


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: UNII:J64RI4D29U

subject_name: Acebilustat


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: hypertension


subject: CHEBI:28787

object_name: Hypertension, CTCAE


subject: CHEBI:9728

subject_name: Trimethaphan


subject: CHEBI:9728


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Cirrhosis


subject: CHEBI:85078

object_name: Hepatic ascites


subject: UNII:G1G66XE93W

object_name: Stage IV Rectal Cancer AJCC v8


subject: UNII:G1G66XE93W

object_name: Stage IV Rectal Cancer AJCC v7


subject: UNII:G1G66XE93W

object_name: Rectal cancer stage IV


subject: UNII:G1G66XE93W

object_name: Stage IV Rectal Cancer AJCC v6


subject: UNII:G1G66XE93W

object_name: Recurrent Rectal Cancer


subject: UNII:G1G66XE93W

object_name: Stage IV Colon Cancer AJCC v8


subject: UNII:G1G66XE93W

object_name: Stage IV Colon Cancer AJCC v6


subject: UNII:G1G66XE93W

object_name: Stage IV Colon Cancer AJCC v7


subject: UNII:G1G66XE93W

object_name: Malignant neoplasm of colon stage IV


subject: UNII:G1G66XE93W

object_name: Colon cancer recurrent


subject: UNII:G1G66XE93W

object_name: colon adenocarcinoma


subject: UNII:G1G66XE93W

object_name: rectum adenocarcinoma


subject: CHEBI:3757

subject_name: Clonidine

object_name: substance-related disorder


subject: CHEBI:3757

object_name: opiate dependence


subject: CHEBI:140628

subject_name: Secnidazole

object_name: bacterial vaginosis


subject: CHEBI:231673

subject_name: Hyaluronidase

object_name: Spasticity


subject: PUBCHEM.COMPOUND:91820602


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Hemorrhagic Shock


subject: CHEBI:94518

object_name: TRAUMA/INJURY PROBLEM


subject: CHEBI:91407

subject_name: Momelotinib

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: GTOPDB:13455

subject_name: felzartamab

object_name: Antibody-mediated rejection


subject: UNII:3O9FA4XC02


subject: UMLS:C3273720


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: prostate carcinoma


subject: CHEBI:175901

object_name: prostate cancer


subject: CHEBI:175901

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:175901

object_name: Stomach cancer


subject: CHEBI:175901

object_name: gastric cancer


subject: CHEBI:175901

object_name: carcinoma of esophagus


subject: CHEBI:175901

object_name: esophageal cancer


subject: CHEBI:175901

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:175901

object_name: melanoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863

object_name: colorectal cancer


subject: CHEBI:45863

object_name: colorectal carcinoma


subject: CHEBI:45863

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: heart failure


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEMBL.COMPOUND:CHEMBL2108924

subject_name: CINNAMON

object_name: abdominal obesity-metabolic syndrome


subject: CHEMBL.COMPOUND:CHEMBL2108924

object_name: metabolic syndrome X


subject: UMLS:C0939899

subject_name: cinnamon preparation


subject: UMLS:C0939899


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: glioblastoma


subject: CHEBI:233362

object_name: Childhood Glioblastoma


subject: CHEBI:233362

object_name: adult glioblastoma


subject: CHEBI:233362

object_name: Recurrent Brain Neoplasm


subject: CHEBI:233362

object_name: brain neoplasm


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Abdominal pain


subject: CHEBI:73604

object_name: Abdominal Pain, CTCAE


subject: GTOPDB:13396

subject_name: ivonescimab

object_name: non-small cell lung carcinoma


subject: GTOPDB:13396

object_name: small cell lung carcinoma


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UNII:Y0O332CU66